[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-339337-105":59,"doc-detail-339337-en":131},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":124,"head_meta":126,"extra_data":128,"updated_unix":130},105,"en","genomic-and-pathologic-profiling-of-very-well-differentiated-gastric-adenocarcinoma-of-intestinal-type-a-study-with-emphasis-on-diffuse-type-transformation","Genomic and Pathologic Profiling of Very Well-Differentiated Gastric Adenocarcinoma of Intestinal Type - A Study With Emphasis on Diffuse-Type Transformation","","Very well-differentiated adenocarcinoma of intestinal type is a distinct gastric cancer subtype defined by anastomosing glands and low-grade cytologic atypia resembling intestinal metaplasia. Although it often follows an indolent course, a subset transforms into higher-grade disease, typically diffuse-type carcinoma, with aggressive behavior. This study characterizes genomic and pathologic features, analyzing cases with and without diffuse-type transformation, and identifying associated molecular alterations and histologic correlates.",{"@graph":69,"@context":123},[70,84,106],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/genomic-and-pathologic-profiling-of-very-well-differentiated-gastric-adenocarcinoma-of-intestinal-type-a-study-with-emphasis-on-diffuse-type-transformation/339337/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/genomic-and-pathologic-profiling-of-very-well-differentiated-gastric-adenocarcinoma-of-intestinal-type-a-study-with-emphasis-on-diffuse-type-transformation/339337.png","ImageObject",300,407,{"name":92,"@type":93},"Aurora","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":105},"InteractionCounter",{"@type":104},"ViewAction",12,{"@type":107,"mainEntity":108},"FAQPage",[109,115,119],{"name":110,"@type":111,"acceptedAnswer":112},"What defines very well-differentiated gastric adenocarcinoma of intestinal type?","Question",{"text":113,"@type":114},"It is characterized by fused or anastomosing neoplastic glands with low-grade cytologic atypia that mimics intestinal metaplasia.","Answer",{"name":116,"@type":111,"acceptedAnswer":117},"Why is diffuse-type transformation clinically important?",{"text":118,"@type":114},"A subset develops poorly cohesive carcinoma within the lesion and undergoes diffuse-type transformation with aggressive behavior, requiring careful clinical management.",{"name":120,"@type":111,"acceptedAnswer":121},"Which genomic and pathologic features were most associated with diffuse-type transformation?",{"text":122,"@type":114},"RHOA mutations were common, and diffuse-type transformation showed significant associations with advanced disease, mixed mucin phenotype, altered p53 expression in higher-grade components, and decreased E-cadherin expression in poorly cohesive components.","https://schema.org",{"og:url":83,"og:type":125,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":127,"canonical":83},"index,follow",{"doc_id":129,"site_id":62},339337,1790218139,{"code":4,"msg":5,"data":132},{"doc_id":129,"user_id":133,"nickname":92,"user_avatar":134,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":105,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":52,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Genomic and Pathologic Profiling of Very WellDifferentiated Gastric Adenocarcinoma of Intestinal Type  \nA Study With Emphasis on Diffuse-Type Transformation  \nHirofumi Rokutan, MD, PhD,* Yasuhito Arai, PhD,† Akiko Kunita, PhD,* Satoshi Yamasaki, PhD,‡ Hiromi Nakamura, MS,† Natsuko Hama, MS,† Atsuhito Nakayama, MD,* Fumie Hosoda, PhD,† Yasushi Totoki, PhD,†§ Mitsuhiro Fujishiro, MD, PhD,∥ Yasuyuki Seto, MD, PhD,¶ Tatsuhiro Shibata, MD, PhD,†‡  \nand Tetsuo Ushiku, MD, PhD*  \nAbstract: Very well-differentiated adenocarcinoma of intestinal type is a distinct subtype of gastric cancer characterized by anastomosing glands with a hand-in-hand pattern and low-grade cytologic atypia resembling intestinal metaplasia. This is a slowgrowing neoplasm with an indolent clinical course; however, a subset demonstrates transformation into adenocarcinoma with higher-grade histology, typically diffuse-type carcinoma, and behaves aggressively. This study aimed to better characterize the genomic and pathologic features, with a focus on factors asso-  \nFrom the Departments of *Pathology; ∥Gastroenterology; ¶Gastrointestinal Surgery; ‡Laboratory of Molecular Medicine, The Institute of Medical Science, The University of Tokyo; †Division of Cancer Genomics, National Cancer Center Research Institute, Tokyo; and §Department of Cancer Genome Informatics, Graduate School of Medicine, Osaka University, Osaka, Tokyo, Japan.  \nThis work was supported by Japan Agency for Medical Research and Development (AMED) under Grant JP21cm0106502h0006 (TU) .  \nThe data supporting the ﬁndings of this study are available from the corresponding author upon reasonable request.  \nThis retrospective study was approved by the Institutional Review Board of Tokyo University Hospital (no. G3521 and G10106) and National Cancer Center (no. G2008-003), Japan, and the requirement to obtain written informed consent was waived.  \nH.R., T.S., and T.U. conceived and designed the study. H.R., Y.A., and  \nA.K. performed sequencing experiments. H.R., Y.A., A.K., S.Y.,  \nH.N., N.H., A.N., F.H., Y.T., T.S., and T.U. analyzed and interpreted data. M.F. and Y.S. provided the clinical information. H.R. and T.U. wrote the manuscript, which was approved by all the authors.  \nConﬂicts of Interest and Source of Funding: The authors have disclosed that they have no signiﬁcant relationships with, or ﬁnancial interest in, any commercial companies pertaining to this article.  \nCorrespondence: Tetsuo Ushiku, MD, PhD, Department of Pathology, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113-8655, Japan (e-mail: [usikut@g.ecc.u-tokyo.ac.jp](usikut@g.ecc.u-tokyo.ac.jp)) .  \nSupplemental Digital Content is available for this article. Direct URL citations are provided in the HTML and PDF versions of this article on the journal’[s website www.ajsp.com](s website www.ajsp.com).  \nCopyright © 2024 The Author(s) . Published by Wolters Kluwer Health, Inc. This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.  \nDOI: 10.1097/PAS.0000000000002222  \n[652](652 | www.ajsp.com)[ |](652 | www.ajsp.com)[ www.ajsp.com](652 | www.ajsp.com)  \nciated with diffuse-type transformation. A total of 58 cases with (n = 31) and without (n = 27) diffuse-type transformation were analyzed for molecular and pathologic features. First, comprehensive deep DNA sequencing was conducted in 18 cases (discovery cohort), followed by a digital droplet polymerase chain reaction of hot spot RHOA mutations in 40 cases (validation cohort) . In total, RHOA mutations were the most common alteration (34%), followed by loss of ARID1A (12%), p53 alterations (10%), and CLDN18::ARHGAP26/6 fusions (3 .4%) . FGFR2 ampliﬁcation was identiﬁed in an advanced case with a p53 alter","cbCaikFMqrCa4kh5","https://ap.wps.com/l/cbCaikFMqrCa4kh5","pdf",1668553,"English","# Abstract\n## Background and clinical relevance\n## Study aim and approach\n## Key molecular and pathologic findings\n## Conclusions and implications","[{\"question\":\"What defines very well-differentiated gastric adenocarcinoma of intestinal type?\",\"answer\":\"It is characterized by fused or anastomosing neoplastic glands with low-grade cytologic atypia that mimics intestinal metaplasia.\"},{\"question\":\"Why is diffuse-type transformation clinically important?\",\"answer\":\"A subset develops poorly cohesive carcinoma within the lesion and undergoes diffuse-type transformation with aggressive behavior, requiring careful clinical management.\"},{\"question\":\"Which genomic and pathologic features were most associated with diffuse-type transformation?\",\"answer\":\"RHOA mutations were common, and diffuse-type transformation showed significant associations with advanced disease, mixed mucin phenotype, altered p53 expression in higher-grade components, and decreased E-cadherin expression in poorly cohesive components.\"}]","Genomic and Pathologic Profiling of Very Well-Differentiated Gastric Adenocarcinoma of Intestinal Type - A Study With Emphasis on Diffuse-Type Transformation | PDF",1790029701,25,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c97497a7349d857f86e54f5655b0eec.webp",983,1315,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5feb01eb62aebbdd9dc4d20bbcc74da.webp",982,1314,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a0df89a6c4faea73b7713a3a28df007b.webp",981,1312,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca6336edf0471fb8ac3f97bdef0523fd.webp",980,1311]